Stem Cell Therapy: Pantanggal Ng Diabetes

A recent breakthrough in China shows promise for reversing Type 1 and Type 2 diabetes using patient-derived stem cells to regenerate insulin-producing beta cells. The therapy, avoiding immune rejection, has shown successful outcomes, eliminating the need for insulin. However, significant obstacles like pharmaceutical resistance and limited access remain before widespread adoption.

Short lived stem cells after COVID-19 and its vaccine

This article is about a study that shows that blood stem cells are decreased in the umbilical blood cord of babies whose mothers recovered from COVID-19 but more so in those who received COVID-19 vaccinations. The paper was published in iScience on November 10, 2022. The investigators are from the University of Alabama at Birmingham….